CONTINEUM THERAPEUTICS INC-A (CTNM)
US21217B1008 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CTNM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 29.24. This target is 79.06% above the current price.
CTNM was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about CTNM.
In the previous month the buy percentage consensus was at a similar level.
CTNM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-22 | Baird | Initiate | Outperform |
| 2024-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-30 | RBC Capital | Initiate | Outperform |
| 2024-04-30 | Stifel | Initiate | Buy |
| 2024-04-30 | Morgan Stanley | Initiate | Overweight |